|
|
.
See Category: Endocrine, nutritional and metabolic diseases
ICD-10 (CM) Code and Descriptor
|
E22.0 |
Acromegaly and pituitary gigantism
|
E220 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 56.35%
|
15.52%
|
8.62%
|
5.49%
|
3.94%
|
2.94%
|
1.95%
|
1.34%
|
0.87%
|
0.70%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for E22.0*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
96372
|
THER/PROPH/DIAG INJ SC/IM |
2,067
|
2,249
|
|
J2353
|
OCTREOTIDE INJECTION, DEPOT |
1,244
|
32,317
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
798
|
806
|
|
84305
|
ASSAY OF SOMATOMEDIN |
774
|
774
|
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
626
|
630
|
|
J1930
|
LANREOTIDE INJECTION |
494
|
49,236
|
|
84439
|
ASSAY OF FREE THYROXINE |
436
|
436
|
|
84443
|
ASSAY THYROID STIM HORMONE |
382
|
382
|
|
80053
|
COMPREHEN METABOLIC PANEL |
346
|
346
|
|
83003
|
ASSAY GROWTH HORMONE (HGH) |
339
|
374
|
|
83036
|
HEMOGLOBIN GLYCOSYLATED A1C |
265
|
265
|
|
84146
|
ASSAY OF PROLACTIN |
229
|
232
|
|
82533
|
TOTAL CORTISOL |
229
|
248
|
|
82306
|
VITAMIN D 25 HYDROXY |
143
|
143
|
|
70553
|
MRI BRAIN STEM W/O & W/DYE |
137
|
139
|
|
84403
|
ASSAY OF TOTAL TESTOSTERONE |
136
|
137
|
|
80048
|
METABOLIC PANEL TOTAL CA |
134
|
134
|
|
82024
|
ASSAY OF ACTH |
127
|
128
|
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
126
|
126
|
|
80061
|
LIPID PANEL |
125
|
125
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
E22.0 related to the following DRG Codes:
643-645
|
